Rothschild & CO Asset Management Us Inc. Eagle Pharmaceuticals, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$38.66 - $51.82 $6.24 Million - $8.37 Million	-161,444 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$36.72 - $67.73 $8.77 Million - $16.2 Million	-238,793 Reduced 59.66%	161,444 $6.51 Million
Q3 2018 Nov 13, 2018	SELL	$66.65 - $83.86 $487,478 - $613,352	-7,314 Reduced 1.79%	400,237 $27.7 Million
Q2 2018 Aug 07, 2018	BUY	$51.25 - $76.62 $20.9 Million - $31.2 Million	407,551 New	407,551 $30.8 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.